We report for the first time that the concentrations of chemotactic chemokines MCP-1 (CCL2), MIP-1β (CCL4), and CXCL16 are significantly higher in the sera and stools of IBS patients compared to healthy volunteers. The gene discussed is CCL2; the disease is irritable bowel syndrome.